Profil
Edward Miller formerly worked at Eloxx Pharmaceuticals, Inc., as Director-Finance & Accounting, Alexion Pharmaceuticals, Inc., as Chief Compliance Officer & Senior Vice President from 2014 to 2017, Boehringer Ingelheim Corp., as Vice President & Associate General Counsel from 2000 to 2014, and AlloVir, Inc., as Secretary & General Counsel.
Mr. Miller received his undergraduate degree from Princeton University and graduate degree from Rutgers Law School.
Anciens postes connus de Edward Miller
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Compliance Officer | 01/05/2017 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Conseiller Juridique Général | 01/01/2014 |
| ELOXX PHARMACEUTICALS, INC. | Directeur Financier/CFO | - |
| ALLOVIRPAR | Conseiller Juridique Général | - |
Formation de Edward Miller
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Rutgers Law School
Rutgers Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AlloVir, Inc.
AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
















